These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35788230)

  • 1. A novel 6-metabolite signature for prediction of clinical outcomes in type 2 diabetic patients undergoing percutaneous coronary intervention.
    Wang XB; Cui NH; Liu X
    Cardiovasc Diabetol; 2022 Jul; 21(1):126. PubMed ID: 35788230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of serum TBA for 2-year MACEs in ACS patients undergoing PCI: a prospective cohort study.
    Wen W; Li Q; She J; Bai X; Zhang L; Li R; Wu Y; Zhou J; Yuan Z
    Sci Rep; 2024 Jan; 14(1):1733. PubMed ID: 38242883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis.
    Li N; Yang YG; Chen MH
    BMC Cardiovasc Disord; 2016 Nov; 16(1):238. PubMed ID: 27887590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
    Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
    Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a prediction model to predict major adverse cardiovascular events in elderly patients undergoing noncardiac surgery: A retrospective cohort study.
    Zhang K; Liu C; Sha X; Yao S; Li Z; Yu Y; Lou J; Fu Q; Liu Y; Cao J; Zhang J; Yang Y; Mi W; Li H
    Atherosclerosis; 2023 Jul; 376():71-79. PubMed ID: 37315395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.
    Wang YP; Wang JH; Wang XL; Liu JY; Jiang FY; Huang XL; Hang JY; Qin W; Ma SX; Zhang J; Yuan MJ; Li JB; Lu ZG; Wei M
    J Cell Mol Med; 2017 Nov; 21(11):2677-2684. PubMed ID: 28623858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine Learning for Early Prediction of Major Adverse Cardiovascular Events After First Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: Retrospective Cohort Study.
    Zhang P; Wu L; Zou TT; Zou Z; Tu J; Gong R; Kuang J
    JMIR Form Res; 2024 Jan; 8():e48487. PubMed ID: 38170581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study.
    He J; Bian X; Song C; Zhang R; Yuan S; Yin D; Dou K
    Cardiovasc Diabetol; 2022 Aug; 21(1):156. PubMed ID: 35964050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes.
    Song L; Zhao X; Chen R; Li J; Zhou J; Liu C; Zhou P; Wang Y; Chen Y; Zhao H; Yan H
    Cardiovasc Diabetol; 2022 May; 21(1):80. PubMed ID: 35596184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
    Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
    Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention.
    Pan D; Xiao S; Hu Y; Pan Q; Wu Q; Wang X; Liu Q; Liu A; Liu J; Zhu H; Zhou Y
    Cardiovasc Ther; 2021; 2021():3758320. PubMed ID: 34987604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are women with type 2 diabetes mellitus more susceptible to cardiovascular complications following coronary angioplasty?: a meta-analysis.
    Bundhun PK; Pursun M; Huang F
    BMC Cardiovasc Disord; 2017 Jul; 17(1):207. PubMed ID: 28750607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediabetes predicts adverse cardiovascular outcomes after percutaneous coronary intervention: a meta-analysis.
    Zhao Y; Guo M; Shi G
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31793983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-hospital, short-term and long-term adverse clinical outcomes observed in patients with type 2 diabetes mellitus vs non-diabetes mellitus following percutaneous coronary intervention: A meta-analysis including 139,774 patients.
    Zhuo X; Zhang C; Feng J; Ouyang S; Niu P; Dai Z
    Medicine (Baltimore); 2019 Feb; 98(8):e14669. PubMed ID: 30813214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Machine Learning Methods With National Cardiovascular Data Registry Models for Prediction of Risk of Bleeding After Percutaneous Coronary Intervention.
    Mortazavi BJ; Bucholz EM; Desai NR; Huang C; Curtis JP; Masoudi FA; Shaw RE; Negahban SN; Krumholz HM
    JAMA Netw Open; 2019 Jul; 2(7):e196835. PubMed ID: 31290991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study.
    Zhang S; Liu X; Song B; Yu H; Zhang X; Shao Y
    BMJ Open; 2022 Jan; 12(1):e052031. PubMed ID: 35022171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the prediction of acute kidney injury risk after percutaneous coronary intervention using machine learning techniques: A retrospective cohort study.
    Huang C; Murugiah K; Mahajan S; Li SX; Dhruva SS; Haimovich JS; Wang Y; Schulz WL; Testani JM; Wilson FP; Mena CI; Masoudi FA; Rumsfeld JS; Spertus JA; Mortazavi BJ; Krumholz HM
    PLoS Med; 2018 Nov; 15(11):e1002703. PubMed ID: 30481186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediabetes versus type 2 diabetes mellitus based on pre-percutaneous coronary intervention thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction after successful newer-generation drug-eluting stent implantation.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Diab Vasc Dis Res; 2021; 18(1):1479164121991505. PubMed ID: 33535819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plaque composition by virtual histology intravascular ultrasound and clinical outcomes after percutaneous coronary intervention in saphenous vein graft disease patients: study protocol of a prospective cohort study.
    Liu Y; Wang HB; Li X; Xiao JY; Wang JX; Reilly KH; Sun B; Gao J
    BMC Cardiovasc Disord; 2018 Dec; 18(1):233. PubMed ID: 30541457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radiomic nomogram for prediction of major adverse cardiac events in ST-segment elevation myocardial infarction.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Eur Radiol; 2021 Feb; 31(2):1140-1150. PubMed ID: 32856164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.